Online Only Articles

TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy

Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome, Italy
Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome, Italy
Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome, Italy
Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome, Italy
GIMEMA Data Center, GIMEMA Foundation, Rome, Italy
Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome, Italy
Roche Molecular Systems, Inc., Pleasanton, CA, USA
Department of Medicine, Section of Hematology, University of Verona, Italy
Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
Department of Hematology, Catholic University of the Sacred Heart, Rome, Italy
Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome, Italy
Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome, Italy
Vol. 98 No. 5 (2013): May, 2013 https://doi.org/10.3324/haematol.2012.076786